Melanoma
Found 4 recent publications
Moderna recorded the sharpest stock increase in the S&P 500 index since 2008
Breaking an 18-year record: The success of clinical trials combining mRNA technology in the fight against cancer has led to an unprecedented surge in Moderna's stock. According to The Wall Street Journal, the company recorded the sharpest daily increase of any S&P 500 firm since 2008.
Breakthrough for Moderna and Merck: Promising results in advanced melanoma vaccine trial
An experimental personalized cancer vaccine for melanoma from Merck and Moderna has shown positive preliminary results in its first late-stage trial. The combination therapy significantly extended the time patients lived without recurrence.
Breakthrough for Moderna and Merck: Promising Results in Advanced Melanoma Vaccine Trial
An experimental personalized cancer vaccine from Merck and Moderna has shown positive preliminary results in a Phase 3 trial. The combination therapy significantly reduced the risk of melanoma recurrence.
Jackie Azoulay on her battle with illness: "I was saved at the last moment"
After revealing that she was saved from an aggressive melanoma and underwent complex back surgery, reality star Jackie Azoulay decided to turn her physical scar into a symbol of strength with a moving tattoo.